Skip to main content
LNA Santé logo

LNA Santé — Investor Relations & Filings

Ticker · LNA ISIN · FR0004170017 LEI · 969500FULTKJYIRIAT87 PA Human health and social work activities
Open in API
Filings indexed 557 across all filing types
Latest filing 2022-09-14 Earnings Release
Country FR France
Listing PA LNA

About LNA Santé

https://www.lna-sante.com/

LNA Santé is a healthcare operator focused on providing care for vulnerable individuals. The company manages and operates a diverse network of facilities, including medicalized nursing homes that offer long-term care and specialized support for neurodegenerative diseases like Alzheimer's and Parkinson's. Its portfolio also includes Medical Care and Rehabilitation (SMR) establishments for post-acute and follow-up care, surgical clinics, and mental health clinics. In addition to its residential and outpatient facilities, LNA Santé provides hospital-at-home (HAD) services, delivering complex medical care directly to patients' residences. The organization's integrated approach serves individuals facing temporary or permanent loss of autonomy, disabilities, or the need for specialized medical treatment and rehabilitation.

Recent filings

Filing Released Lang Actions
LNA SANTE: Résultats Semestriels 2022
Earnings Release Classification · 100% confidence The document is titled "RESULTATS DU 1er SEMESTRE 2022" (First Half 2022 Results) for LNA Santé. It contains detailed financial tables (CA, EBITDA, EBIT, Net Result) comparing H1 2022 to H1 2021, discusses operational metrics like occupancy rates, and provides management commentary on performance and outlook. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year (six months). Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not a brief announcement (RPA/ER) because it contains the full breakdown and analysis, and it is not the Annual Report (10-K) as it covers only the first half of the year. H1 2022
2022-09-14 French
LNA Santé: répartition de capital et des droits de vote attachés aux actions au 31/08/2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides the "Répartition de capital et des droits de vote attachés aux actions au 31/08/2022" (Capital and voting rights breakdown as of 08/31/2022). This content specifically details the total number of shares, gross voting rights, and exercisable voting rights, which is a mandatory regulatory disclosure in France concerning share capital structure and voting power. This type of disclosure, focusing on capital structure and voting rights, aligns best with the 'Share Issue/Capital Change' (SHA) category, as it reports on the fundamental components of the company's capital base and associated voting power, even though it's a periodic update rather than a transaction announcement. It is not a general earnings release (ER), a full annual report (10-K), or a management change announcement (MANG). Given the focus on capital structure reporting, SHA is the most appropriate fit.
2022-09-05 French
LNA Santé: répartition de capital et des droits de vote attachés aux actions au 31/07/2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" (Declaration under Article 223-16 of the General Regulation of the AMF) and provides the "Répartition de capital et des droits de vote attachés aux actions au 31/07/2022" (Distribution of capital and voting rights attached to shares as of 07/31/2022). This type of mandatory disclosure, detailing the total number of shares and voting rights, is a standard regulatory filing in France, often related to major shareholdings or capital structure updates, but it is not a comprehensive report like a 10-K or IR. Since it is a specific regulatory declaration concerning capital structure and voting rights, and it doesn't fit perfectly into the defined categories like DIRS (Director's Dealing) or MRQ (Major Shareholding Notification - which usually reports *changes* by specific entities), the most appropriate general category for specific, non-standard regulatory disclosures that impact capital structure reporting is Regulatory Filings (RNS). However, given the content explicitly details the total capital and voting rights, which is a fundamental component of capital structure reporting, and considering the options, RNS serves as the best fit for a specific regulatory declaration that isn't a standard financial report or a specific insider/shareholder change report.
2022-08-16 French
LNA SANTE: Chiffre d'Affaires 1er semestre 2022
Earnings Release Classification · 99% confidence The document is a press release dated July 26, 2022, detailing the financial results for the 'Premier semestre 2022' (First Half 2022). It presents key figures like 'Chiffre d'affaires Exploitation' (Operating Revenue) for H1 2022 (€334.5 M) and Q2 2022, along with commentary from the Chairman and operational details. This content structure—a formal announcement of financial performance for a period shorter than a full year (six months)—is characteristic of an Interim/Quarterly Report (IR). It is not the full Annual Report (10-K), nor is it just a brief Earnings Release (ER) announcing results; it provides substantial detail on segments and outlook. The document also mentions the upcoming full H1 2022 results publication date (September 14), but this document itself is the preliminary release of those H1 results. H1 2022
2022-07-26 French
Communiqué de presse - Augmentation de moyen au contrat de liquidité - 21/07/22
Capital/Financing Update Classification · 98% confidence The document is a press release dated July 21, 2022, announcing an 'AUGMENTATION DE MOYEN AU CONTRAT DE LIQUIDITE AVEC ODDO BHF SCA' (Increase in resources allocated to the liquidity contract with ODDO BHF SCA). This action directly relates to the company managing its share capital or liquidity provisions, specifically by increasing the cash allocated to the liquidity contract as per AMF regulations. This falls under financing activities or capital structure changes. The most appropriate category is 'Capital/Financing Update' (CAP). It is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV).
2022-07-21 French
LNA Santé: répartition de capital et des droits de vote attachés aux actions au 30/06/2022
Share Issue/Capital Change Classification · 95% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" (Declaration under Article 223-16 of the General Regulation of the AMF) and provides the "Répartition de capital et des droits de vote attachés aux actions au 30/06/2022" (Distribution of capital and voting rights attached to shares as of 06/30/2022). This content specifically details the total number of shares, gross voting rights, and exercisable voting rights. This type of mandatory disclosure regarding capital structure and voting rights is a specific regulatory filing, but it does not fit perfectly into the defined categories like 10-K, IR, or ER. It is a specific regulatory disclosure concerning share capital and voting rights. Given the options, it is a specific regulatory announcement. Since it is not a general announcement of a report (RPA) or a standard miscellaneous filing (RNS), and it deals directly with capital structure and voting rights, it is closest to a regulatory filing that isn't covered elsewhere. However, looking closely at the definitions, it is a specific disclosure about the capital structure and voting rights, which is often a component of broader filings or specific regulatory mandates. Since there is no specific code for 'Voting Rights Disclosure' other than DVA (Declaration of Voting Results), and this is a periodic capital/voting rights statement rather than the *results* of a vote, the most appropriate fallback for a specific, non-standard regulatory disclosure is RNS (Regulatory Filings/Miscellaneous). If the document were about changes in major shareholdings (MRQ), that would be closer, but this is the company reporting its own total structure. Given the nature of mandatory regulatory reporting on capital structure, RNS is the best fit as a catch-all for specific regulatory disclosures not explicitly defined.
2022-07-07 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.